0% found this document useful (0 votes)
73 views45 pages

Vitreoretina: DR - Reinne Natali Christine, SPM Dept. Ilmu Penyakit Mata FK Uki / Rsu FK Uki

The document discusses the retina and vitreous. It describes the layers of the retina including the retinal pigment epithelium and layers containing rods and cones. It discusses retinal receptors including rods functioning in dim light and cones enabling color vision. Common retinal disorders are mentioned such as diabetic retinopathy, retinal detachment, and retinal vascular occlusions. Diagnostic tests and treatments for various retinal conditions are summarized.

Uploaded by

tusuksedotan
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
73 views45 pages

Vitreoretina: DR - Reinne Natali Christine, SPM Dept. Ilmu Penyakit Mata FK Uki / Rsu FK Uki

The document discusses the retina and vitreous. It describes the layers of the retina including the retinal pigment epithelium and layers containing rods and cones. It discusses retinal receptors including rods functioning in dim light and cones enabling color vision. Common retinal disorders are mentioned such as diabetic retinopathy, retinal detachment, and retinal vascular occlusions. Diagnostic tests and treatments for various retinal conditions are summarized.

Uploaded by

tusuksedotan
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 45

VITREORETINA

dr.Reinne Natali Christine, SpM


Dept. Ilmu Penyakit Mata
FK UKI / RSU FK UKI
RETINA

• The innermost layer of the eyeball.

• It is extremely thin and transparent


(0.5mm)

• It contains visual receptors of the eye

• The retinal neurons transmit the picture


through the optic nerve fibers to brain for
perception
STRUCTURE OF THE RETINA

• There are 10 layers in the retina

• Retinal pigment epithelium


• Layer of rods and cones
• External limiting membrane
• Outer nuclear layer
• Outer plexiform layer
• Inner nuclear layer
• Inner plexiform layer
• Ganglion cell layer
• Nerve fibre layer
• Internal limiting membrane
RETINAL RECEPTORS
THE RETINAL RECEPTORS ARE DIVIDED INTO TWO MAIN POPULATIONS

Rods Cones

• Function best in dim light • Function best in daylight


• There are 125million rods in the • There 6 million cones in the
retina retina
• Rods are relatively poor in visual • Cones enable us to see small
details visual details
• Helps to visualize the colors
FOVEA AND ORA SERRATA

• The cones form a concentrated area in the retina known as fovea (no rods)
• It lies in the center of the macula lutea
• The junction of the periphery of the retina and ciliary body is called ora
serrata
VITREOUS

• The Vitreous humour is a transparent gel that provides a clear optical medium.
• It is helps to keep the three layers apposed to each other
• It occupies approximately 80% of the volume of the globe.
• The vitreous consist of water, collagen fibrils, molecules of hyaluronic acid, peripheral
cells and mucopolysacharides forming a gel like material.
• It nourishes lens, ciliary body and the retina.
RETINAL DIAGNOSTIC TESTS

• Fundus Photography
• Fluorescein Angiography (FA)
• Optical Coherence Tomography (OCT)
• Ocular Ultrasonography
• Electroretinography (ERG)
DISORDER OF RETINA AND VITREOUS

Hereditary retinal Vascular (arteri or


Diabetic retinopathy
disorder vein ) occlusion

Age related macular


degeneration and
Retinal detachment
choroidal
neovascularization
HEREDITARY CONGENITAL RETINAL DYSTROPHIES

1. RETINITIS PIGMENTOSA
2. LEBER CONGENITAL AMOUROSIS
3. CONE-ROD DYSTROPHIES
4. MACULA DYSTROPHIES
DIABETIC RETINOPATHY

Year No of adults with People with DR


diabetes in
Indonesia*
2010 (9th) 6,964,000 2,409,544

2030 (6th) 11,980,000 4,145,080

*J.E.Shaw, R. A. Sicree, Global estimates of the prevalence of diabetes for


2010 and 2030, Diabetes Research and Clinical Practice 87 (2010) 4-14

According to IDF (2014), Indonesia already in the 6th rank worldwide with no.
DM case was 9,116,030

10
PATHOPHYSIOLOGY

• The exact cause of diabetic microvascular disease is unknown.


• Exposure to hyperglycemia over an extended period results in biochemical and
physiologic changes that ultimately cause endothelial damage.
• Specific retinal capillary changes :
- selective loss of pericytes
- basement membrane thickening
- changes that favor capillary occlusion and retinal nonperfusion
CLASIFICATION

NPDR PDR
(Non Proliverative Diabetic Retinopathy) (Proliferative Diabetic Retinopathy)

•Loss of retinal capillary pericytes


• Weakens capillary walls • Hallmark is retinal neovascularization
• Causes non-perfusion in capillary beds – response to ischemia from capillary
and hypoxia closure grow onto lattice of vitreous
• Divided into mild, moderate, and severe – new vessels are fragile and easily
(and very severe) rupture
• Divided into 2 : High risk and advance
MECHANISMS OF VISION LOSS

• Retinal ischemia
• Macular edema
• Vitreous hemorrhage
• Epiretinal membrane formation
• Retinal detachment
• Neovascular glaucoma
NPDR
NPDR OCT
PDR
VITREOUS HEMORRHAGE (VH)
VH ULTRASOUND
TRD ULTRASOUND
EPIRETINAL MEMBRANE
TREATMENT

• NPDR without macular edema :


• Observe

• Macular edema :
• 1. Focal/Grid laser photocoagulation
• 2.Vitrectomy with membrane peeling
• 3. Intraocular Steroid*
• 4. Intraocular VEGF inhibitor*
* Off-label use, contraversial
TREATMENT

• Vitreous Hemorrhage:
• 1. Pan-retinal photocoagulation
• 2.Vitrectomy with laser photocoagulation
• 3. Intraocular VEGF inhibitor*

• Traction Retinal Detachment :


• 1. Observation if not involving the macula
• 2.Vitrectomy with membrane dissection

* Off-label use, contraversial


RETINAL VASCULAR OCCLUSION

• Arteri :
Central Retinal Arteri Occlusion ( CRAO)
Branch Retinal Arteri Occlusion ( BRAO)
• Vein
Central Retinal Vein Occlusion ( CRVO)
Branch Retinal Vein Occlusion ( BRVO)
CENTRAL RETINA ARTERY OCCLUSION
(CRAO)

• Unilateral, painless, acute vision loss (counting fingers to light perception in 94% of eyes)
• Occuring over seconds, may have a history of amaurosis fugax.
• Signs:
- A marked afferent pupillary defect
- Narrowed retinal arterioles; box-carring or segmentation of the blood column in
the arterioles.
Clinical finding in CRAO

• VA < 6/60
• APD - marked
• Retinal whitening
• ‘Cherry-red spot’ at macula
• Arteriolar and venular narrowing
• Sludging and segmentation of
blood column (cattle-trucking)
• Very poor prognosis
MANAGEMENT

1. Immediate ocular massage


2. Anterior – chamber paracentesis
3. Acetazolamide, 500 mg I.v. or two 250-mg tablets, p.o and/or a tropical -blocker (e.g.
timolol, or levobunolol, 0.5% b.I.d.) is used to reduce the intraocular pressure
BRANCH RETINAL ARTERI OCCLUSION

• Acute BRAO may not initially be apparent ophthalmoscopically, within hours to days
• It leads to an edematous opacification caused by infarction of the inner retina in the
distribution of the affected vessel
BRANCH RETINAL VEIN OCCLUSION

• Portion of retina involved


• Mostly temporal
- 62% Superotemporal
- 38% Inferotemporal
• Nasal – uncommon & asymptomatic
• Occurs exclusively at arterial overcrossing at
AV intersection by a thrombus
CENTRAL RETINAL VEIN OCCLUSION

Pathogenesis :

Thrombosis of the central retinal vein at and posterior to the level of the lamina cribrosa.

In some cases, a thickened central retinal artery may impinge on the central retinal vein
 turbulence  Endothelial damage  thrombosis
In CRVO vision loss is most commonly sudden:

Mild vision loss  nonischemic CRVO

Severe vision loss  ischemic CRVO

Less commonly, patients may experience premonitory symptoms

of transient visual obscuration before overt retinal manifestations

appear.
SIGNS

Decreased visual acuity


RAPD: +
Marked venous dilation
Severe splinter and dot hemorrhage in four quadrant
Cotton-wool spots
Macular edema
MANAGEMENT

• Current treatment is directed at secondary complications of CRVO that affect vision,


including:
a. Macular edema  Laser photocoagulation
 Anti VEGF injection ( Ranibizumab,
b. Retinal neovascularization Bevazicumab)
c. Neovascularization iris  Anti glaucoma medicine (if needed)

d. Neovascular Glaucoma
e. Retinal Detachment
• Treatment also involves management of predisposing risk factors, such as diabetes,
hypertension and hyper-lipidemia
RETINAL DETACHMENT

There are three distinct types of retinal detachment (RD). All three forms
show an elevation of retina.
A.Rhegmatogenous (RRD)
B. Non Rhegmatogenous :
- Tractional (TRD)
- Exudative
Indirect ophthalmology
Condensing lenses Technique

• The higher the power, the less the • Keep lens parallel to patient’s iris plane
magnification, the shorter the working • Avoid tendency to move towards patient
distance but the greater the field of view • Ask the patient to move eyes and head
into optimal positions for examination
RHEGMATOGENOUS (RRD)

• Symptoms
- Flashes of light
- Floaters
- a curtain or shadow moving over the field of vision
- peripheral or central visual loss or both.
• Critical Sign
Elevation of the retina with an accompanying retinal break(s)
Pathogenesis of rhegmatogenous RD
Two components for retinal break formation
• Acute posterior vitreous detachment (PVD)
• Predisposing peripheral retinal degeneration

Possible sequelae of acute PVD

Uncomplicated PVD (85%) Retinal tear formation and Avulsion of retinal vessel and
haemorrhage (10-15%) haemorrhage (uncommon)
ANOTHER SIGNS

• Pigmented cells in the anterior vitreous

• Vitreous hemorrhage

• Posterior vitreous detachment

• Lower intraocular pressure (IOP) in the affected eye

• The detached retina is often corrugated in appearance.

• An afferent pupillary defect (APD) may be present.


EXUDATIVE RETINAL DETACHMENT

• Symptoms
Minimal – to – severe visual loss or visual – field defect
• Critical Sign :
- Serous elevation of the retina with shifting subretinal fluid (SRF)
- The area of detached retina changes when the patient changes position:
While sitting, the SRF accumulates inferiorly, detaching the retina inferiorly; while in
the supine position, the fluid accumulates in the posterior pole, detaching the macula.)
- There is no retinal break.
• Etiology
• Neoplastic (e.g,choroidal malignant melanoma, metastasis, choroidal
hemangioma, multiple myeloma, capillary retinal hemangioma )
 Fluorescein angiogram and ultrasound may be helpful in making a
differential diagnosis
• Inflamatory disease (e.g,Vogt-Koyanagi-Harada (VKH) syndrome,
posterior scleritis, other chronic inflamatory processes)
• Critical Sign :
- Serous elevation of the retina with shifting subretinal fluid (SRF)
- The area of detached retina changes when the patient changes position:
While sitting, the SRF accumulates inferiorly, detaching the retina inferiorly; while in
the supine position, the fluid accumulates in the posterior pole, detaching the macula.)
- There is no retinal break.
TRACTIONAL RETINAL DETACHMENT

• Symptoms :

Visual loss or visual – field defect; may be asymtomatic

• Critical Signs

- The detached retina appears concave with a smooth surface

- Vitreous membranes exerting traction on the retina are present.

(Detachment may become a convex RRD if a tractional retinal tear

develops.)
Other Signs
- The retina is immobile, and the detachment rarely extends to the ora serrata.
- A mild APD may be present.
Etiology
- Fibrous bands in the vitreous
(e.g. resulting from proliferative diabetic retinopathy, sickle-cell
retinopathy, retinopathy of prematurity, toxocariasis, trauma,
previous giant retinal tear)
- Contract and detach the retina.
PRINCIPLES OF RETINALDETACHMENT SURGERY

1. Scleral buckling • Configuration of buckles


• Preliminary steps
• Localization of breaks
• Cryotherapy
• Insertion of local explant
• Encircling procedure
• Drainage of subretinal fluid
• Causes of early failure
2. Pneumatic retinopexy
• Giant tears
3. Vitrectomy
• Proliferative vitreoretinopathy (PVR)
• Diabetic tractional RD
THANK YOU

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy